A user shared their interest in using Thymosin Beta-4 to address persistent brain fog resulting from a mild traumatic brain injury (mTBI). Having struggled with the condition for six years, they highlighted the peptide’s researched neuroprotective and neurorestorative potential as a primary reason for their interest.